Newsletter January 2023 No.213

Top News

The President of the Pharmaceutical Association of Japan to speak at a special session at Nikkei Cross Health EXPO 2022
Directions and Challenges for Pharmaceutical Companies' Transformation in the Era of Innovation Ecosystems

The Nikkei Cross Health EXPO 2022, organized by Nikkei BP, was held online from October 11 to 21, 2022. This EXPO is a specialized event connecting all industries, business sectors, and people involved in healthcare. On October 21, the final day of the event, a special session titled "How to Establish an Attractive Healthcare Ecosystem in Japan" was held. The speakers for the special session were Mr. Toshiharu Furukawa, Member of the House of Councilors and Professor of Surgery at Keio Law School and Faculty of Medicine, Mr. Yasushi Okada, Chairman of the Pharmaceutical Manufacturers Association of Japan, Mr. Iwao Kurose, Executive Director of the Japan Medical Association, and Mr. Kazuto Ihara, Director of the Health Insurance Bureau, Ministry of Health, Labor and Welfare. The session theme was "How to Establish an Attractive Healthcare Ecosystem in Japan," which was discussed through presentations by the speakers and a panel discussion. The following is a transcript of Chairman Okada's presentation.

Topics

Policy Research Institute page

Drug Lag: A Comparison of the Status of Unapproved Drugs in Japan and Europe - Based on U.S. Approved Drugs from 2010 to 2021

From JPMA

New Year's Message for 2023

Information

Share this page

TOP